We assign a fundamental rating of 0 out of 10 to IBO. IBO was compared to 191 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of IBO have multiple concerns. IBO does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

IBO had negative earnings in the past year.
IBO had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -201.86%, IBO is not doing good in the industry: 89.01% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-201.86%
ROE	N/A
ROIC	N/A

ROA(3y)-48.88%

ROA(5y)N/A

ROE(3y)-207.06%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IBO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IBO has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for IBO is higher compared to a year ago.

2.2 Solvency

IBO has an Altman-Z score of -4.98. This is a bad value and indicates that IBO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.98, IBO is doing worse than 64.40% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-4.98

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.06 indicates that IBO may have some problems paying its short term obligations.
The Current ratio of IBO (0.06) is worse than 96.86% of its industry peers.
IBO has a Quick Ratio of 0.06. This is a bad value and indicates that IBO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.04, IBO is not doing good in the industry: 96.34% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.06
Quick Ratio	0.04

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IBO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -509.26%.

EPS 1Y (TTM)-509.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1423.03%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.